Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viability Assay for Modern Cytotoxicity Analysis

Executive Summary: The Cell Counting Kit-8 (CCK-8) is a water-soluble tetrazolium salt-based kit using WST-8 to assess cell viability via mitochondrial dehydrogenase activity (ApexBio). The CCK-8 assay delivers superior sensitivity, reproducibility, and procedural simplicity compared to legacy MTT or XTT assays (GS967 article). Its quantitative readout directly reflects viable cell numbers and is broadly used in cancer, neurodegenerative, and cytotoxicity research (Qin et al., 2025). The method is validated for high-throughput, microplate-based formats. Limitations include dependence on intact mitochondrial activity and incompatibility with certain reducing agents.

Biological Rationale

Cell viability and proliferation measurements are central to biomedical research, particularly for studying cancer, neurodegenerative diseases, and drug cytotoxicity. The quantification of living cells is usually based on metabolic activity, which serves as a surrogate marker for cell health and proliferation (GS967, 2023). Mitochondrial dehydrogenases catalyze the reduction of tetrazolium salts in metabolically active cells, producing colored formazan or dye products. Unlike earlier colorimetric assays (e.g., MTT, XTT), which generate insoluble products, CCK-8 leverages WST-8, a water-soluble tetrazolium salt, resulting in a soluble, quantifiable dye (Histone-H2A, 2023). This property simplifies the workflow and improves reproducibility.

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

The core of the CCK-8 assay is the WST-8 compound, a water-soluble tetrazolium salt. Upon addition to cultured cells, WST-8 is reduced by intracellular dehydrogenases—primarily mitochondrial—present only in viable cells. The reduction produces a yellow-orange water-soluble formazan dye, measurable at 450 nm by a microplate reader (ApexBio product page). The amount of dye is directly proportional to the number of viable cells.

This enzymatic conversion is non-toxic and does not require cell lysis, allowing for real-time monitoring or subsequent downstream assays. The water-solubility of the formazan obviates the need for additional solubilization steps required by MTT assays. The reaction is typically performed at 37°C, 5% CO₂, in standard culture media.

Evidence & Benchmarks

• CCK-8 demonstrates linear response between cell number and absorbance (A₄₅₀) over a broad dynamic range, enabling accurate quantification from 100 to 100,000 cells/well (Qin et al., 2025, https://doi.org/10.1038/s41467-025-60115-7).
• The assay detects subtle differences in proliferation and cytotoxicity, outperforming MTT and XTT in sensitivity and convenience (GS967, https://gs967.com/).
• CCK-8 yields reproducible results in high-throughput formats, with intra-assay CV < 5% under standardized conditions (ApexBio, product documentation).
• The method is validated in models of ovarian cancer to track proliferation and viability, supporting mechanistic studies of glycolysis and oncogenic signaling (Qin et al., 2025, DOI).
• CCK-8 is compatible with most standard culture media and does not interfere with common supplements, except for certain reducing agents (Histone-H2A, link).

This article extends benchmarking previously described in GS967 by providing direct citation of peer-reviewed cancer research models.

Applications, Limits & Misconceptions

CCK-8 is widely used for:

• Cell proliferation and viability measurement in cancer and neurodegenerative disease research (Qin et al., 2025).
• Drug cytotoxicity testing in pharmacological screening (ApexBio).
• Assessment of metabolic activity linked to mitochondrial function (DilutionBuffer, 2023).
• Quantitative analysis for high-throughput screening using 96- or 384-well plates.

This review clarifies and updates the mechanistic context highlighted in Histone-H2A, connecting CCK-8 utility to recent cancer signaling discoveries.

Common Pitfalls or Misconceptions

• Does not directly measure cell death: CCK-8 quantifies metabolic activity, not specific cell death pathways (e.g., apoptosis vs. necrosis).
• Not suitable for samples with high reductant content: Strong reducing agents (e.g., β-mercaptoethanol) in media can produce false positives by reducing WST-8 non-enzymatically.
• Mitochondrial dysfunction confounds results: Cells with impaired mitochondrial dehydrogenase activity may yield artificially low signal even if viable.
• Cell density extremes distort linearity: Over-confluent or sparsely plated wells can yield non-linear absorbance responses.
• Not validated for in vivo tissue samples: CCK-8 is designed for in vitro cultured cells; in vivo tissue homogenates or complex matrices require alternative methods.

Workflow Integration & Parameters

For optimal results, seed cells into a 96-well plate (100–10,000 cells/well recommended), allow attachment overnight, and treat as required. Add 10 µl CCK-8 solution per 100 µl culture medium per well. Incubate at 37°C, 5% CO₂, for 1–4 hours; the color intensity increases with incubation time and cell number. Measure absorbance at 450 nm using a microplate reader. Do not use phenol red-containing media for maximal sensitivity.

The K1018 kit is compatible with automated platforms and allows real-time, non-destructive measurement, facilitating downstream molecular analyses. For detailed protocol adaptation and troubleshooting, refer to internal resources such as PDL-1.com, which explores immunological applications not discussed in this article.

Conclusion & Outlook

Cell Counting Kit-8 (CCK-8) represents a modern, sensitive, and convenient approach for cell viability and cytotoxicity analysis in vitro. Its reliance on WST-8 and water-soluble dye formation provides a distinct advantage over traditional MTT assays. The method is validated in cancer research, including models examining glycolytic flux and the PI3K/AKT pathway (Qin et al., 2025). Limitations include sensitivity to mitochondrial status and reductant interference. Ongoing improvements in assay chemistry and workflow integration continue to expand the utility of CCK-8 in basic and translational research.